Use of cytokine inhibitors

Details Use of cytokine inhibitors Use of cytokine inhibitors

2002-03-08

2008-09-23

Mondesi, Robert B. (Department: 1652)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

Reexamination Certificate

active

07427589

ABSTRACT:
The present invention relates to a method for prevention or reduction of scar tissue and/or adhesion formation wherein a therapeutically effective amount of a substance that inhibits a pro-inflammatory cytokine such as TNF or IL-1, is administered to a patient in need of said treatment.

REFERENCES:
patent: 5196430 (1993-03-01), Mandrell et al.
patent: 5994376 (1999-11-01), Freyne et al.
patent: 6348602 (2002-02-01), Fowler et al.
patent: 2002/0072596 (2002-06-01), Ruben et al.
patent: WO 89/05145 (1989-06-01), None
patent: WO 98/06715 (1998-02-01), None
patent: WO 01/57018 (2001-08-01), None
patent: WO 01/58469 (2001-08-01), None
STN International, File ZCAPLUS, Accession No. 2002: 199887, Document No. 136:323691, Kaser, Arthur et al., “Infliximab in Severe Steroid-Refractory Ulcerative Colitis: A Pilot Study”, & Wiener Klinische Wochenschrift (2001), 113(23-24), 930-933.
STN International, File MEDLINE, Accession No. 2000046083, Document No. 20046083, Heller T. et al., “Treatment of Severe Esophageal Crohn's Disease With Infliximab”, & Inflammatory Bowel Diseases, (Nov. 1999) 5 (4) 279-82.
STN International, File MEDLINE, Accession No. 2001011857, Document No. 20409486, Jojic N., [Pharmacotherapy of Inflammatory Bowel Disease]. “Farmakoterapija Inflamatornih Bolesti Creva”, & Acta Chirurgica Jugoslavica, (2000) 47 (1-2) 51-5.
STN International, File MEDLINE, Accession No. 2001419273, Document No. 21360250, Blam M.E., “Integrating Anti-Tumor Necrosis Factor Therapy in Inflammatory Bowel Disease: Current and Future Perspectives”, American Journal of Gastroenterology, (Jul. 2001) 96(7) 1977-97.
STN International, File MEDLINE, Accession No. 2001553668, Document No. 21486185, Travis S.P. et al., “Treatment of Intestinal Behcet's Syndrome With Chimeric Tumour Necrosis Factor Alpha Antibody”, & Gut, (Nov. 2001) 49 (5) 725-8.
Black L.E. “Pharmacology review of infliximab BLA”—May 21, 1998—found at internet address: http://www.fda.gov/cder/biologics/review/inflcen082498r4.pdf.
Rekdal et al., “Construction and synthesis of Lactoferricin Derivatives with Enhanced Antibacterial Activity”,Journal of Peptide Science, 1999, pp. 32-45, vol. 5, University of Tromsø, Norway.

Affiliated with

Also associated with

Rating

Use of cytokine inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of cytokine inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of cytokine inhibitors will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3966195